Sen. Josh Hawley

This resolution expresses support for observing National Trafficking and Modern Slavery Prevention Month during the period of January 1-February 1, 2022.

Slave-Free Business Certification Act of 202 2 This bill requires businesses with annual revenue greater than $500 million to audit their supply chains for labor practices or human trafficking activities that violate specified national or international standards and report the results to the Department of Labor.

No People's Liberation Army in Logistical Operations and Other Pertinent Humanitarian Operations Leading to Endangered Security Act or the No PLA LOOPHOLES Act This bill increases restrictions on military-to-military exchanges or contacts between the U.S. Armed Forces and the Chinese military. Specifically, the bill expands an existing prohibition on exchanges or contacts that include inappropriate exposure to advanced logistical operations to cover logistical operations instead. Additionally, the bill eliminates an exception to the prohibited exchanges or contacts in the case of search and rescue or humanitarian operations or exercises.

Ghost Army Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to the 23rd Headquarters Special Troops and the 3133rd Signal Services Company, known collectively as the Ghost Army , in recognition of unique and highly distinguished service during World War II.

Child Tax Credit for Pregnant Moms Act of 2022 This bill allows a child tax credit for an unborn child who is born alive. It also allows the credit upon certification that a mother's pregnancy resulted in a miscarriage (the involuntary death of an unborn child who was carried in the womb for less than 20 weeks) or that the child was stillborn (the involuntary death of an unborn child who was carried in the womb for 20 weeks or more).

This resolution supports the recognition of a Day of Tears and encourages memorializing those who have lost their lives to abortion by lowering the U.S. flag to half-staff on January 22 every year.

Financial Accountability for Uniquely Compensated Individuals Act or the FAUCI Act This bill broadens the scope of executive branch employees and officers whose financial disclosures are subject to automatic electronic publication by including highly compensated executive branch officers and employees. The bill also requires the Office of Government Ethics to provide public access to a list of highly compensated executive branch officers and employees who file confidential financial disclosures under existing law, including the specific types of information disclosed in the confidential report.

Restore Parental and Consumer Medical Rights in the Nation's Capital Act This bill nullifies the following actions of the government of the District of Columbia: Order 2021-148 issued by the Mayor on December 22, 2021 (relating to vaccination requirements for entrance into certain indoor establishments and facilities); and the Coronavirus Immunization of School Students and Early Childhood Workers Amendment Act of 2021 (D.C. Act 24-285), enacted by the District of Columbia Council on January 12, 2022.

Banning Insider Trading in Congress Act This bill prohibits a member of Congress or spouse of a member of Congress from holding, purchasing, or selling certain investments. Any profit made in violation of the prohibition must be disgorged to the Treasury and may subject the member of Congress to a civil fine. The bill also requires each member of Congress to submit an annual certification of compliance and requires the Government Accountability Office to conduct a compliance audit. The prohibition does not apply to assets held in a qualified blind trust or to a sale by a member of Congress or spouse within 180 days after the bill is enacted or within 180 days after the member commences service, for any member who commences service after the bill is enacted.

Creating Efficiency in Foreign Facility Inspections Act This bill prohibits, with some exceptions, the Food and Drug Administration (FDA) from providing notification in advance of a planned inspection of an establishment located outside of the United States that is engaged in drug manufacturing, processing, packing, or holding. Specifically, the FDA may not provide such an establishment advance notification of a planned inspection unless (1) advance notification is required by the laws of the country where the establishment is located; (2) providing advance notification is needed to protect the public health; or (3) the inspection in question is a preapproval, prelicensure, or for-cause inspection. If the FDA must provide advance notification, it must minimize the time between the notification and the inspection. If an establishment is located in a country that, on or after the date this bill is enacted, enacts a law requiring advance notification of inspections, the drug manufacturer must agree to waive the right to enforce the requirement, to the extent expressly permitted by the law.